Parsec Financial Management, Inc. Abb Vie Inc. Transaction History

Parsec Financial Management, Inc.

$2.37 Billion
Q1 2023

A detailed history of Parsec Financial Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 81,583 shares of ABBV stock, worth $14.3 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

81,583

Previous 80,493 1.35%

Holding current value

$14.3 Million

Previous $13 Million 0.12%

% of portfolio

0.55%

Previous 0.58%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 06, 2023	BUY	$144.61 - $166.54 $157,624 - $181,528	1,090 Added 1.35%	81,583 $13 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $273,715 - $328,256	-1,979 Reduced 2.4%	80,493 $13 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $498,590 - $571,849	-3,715 Reduced 4.31%	82,472 $11.1 Million
Q2 2022 Jul 06, 2022	BUY	$137.62 - $174.96 $404,465 - $514,207	2,939 Added 3.53%	86,187 $13.2 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $1.62 Million - $2 Million	12,244 Added 17.24%	83,248 $13.5 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $760,389 - $962,112	7,078 Added 11.07%	71,004 $9.61 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $1.08 Million - $1.22 Million	10,132 Added 18.83%	63,926 $7.39 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $1.82 Million - $2.03 Million	17,335 Added 47.55%	53,794 $6.06 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $2.55 Million - $2.81 Million	24,959 Added 217.03%	36,459 $3.95 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $102,463 - $138,336	1,273 Added 12.45%	11,500 $1.23 Million
Q3 2020 Nov 06, 2020	SELL	$85.91 - $100.83 $27,061 - $31,761	-315 Reduced 2.99%	10,227 $896,000
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $77,552 - $103,776	-1,057 Reduced 9.11%	10,542 $1.04 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $102,619 - $155,583	-1,591 Reduced 12.06%	11,599 $884,000
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $36,137 - $45,215	501 Added 3.95%	13,190 $1.17 Million
Q3 2019 Oct 23, 2019	SELL	$62.98 - $75.72 $240,205 - $288,796	-3,814 Reduced 23.11%	12,689 $961,000
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $255,901 - $327,102	3,895 Added 30.89%	16,503 $0
Q1 2019 Apr 25, 2019	BUY	$77.14 - $90.79 $88,479 - $104,136	1,147 Added 10.01%	12,608 $1.02 Million
Q4 2018 Jan 29, 2019	BUY	$77.85 - $96.01 $365,583 - $450,862	4,696 Added 69.42%	11,461 $1.06 Million
Q3 2018 Oct 30, 2018	BUY	$88.91 - $98.84 $64,459 - $71,659	725 Added 12.0%	6,765 $640,000
Q2 2018 Jul 26, 2018	SELL	$89.78 - $106.23 $14,813 - $17,527	-165 Reduced 2.66%	6,040 $560,000
Q1 2018 Apr 25, 2018	SELL	$92.01 - $123.21 $1.26 Million - $1.69 Million	-13,701 Reduced 68.83%	6,205 $587,000
Q4 2017 Jan 26, 2018	SELL	$89.56 - $98.21 $87,321 - $95,754	-975 Reduced 4.67%	19,906 $1.93 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $1.46 Million - $1.86 Million	20,881	20,881 $1.86 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parsec Financial Management, Inc. with notifications on news.

Account

Parsec Financial Management, Inc. Abb Vie Inc. Transaction History